Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve 1. To Approve the Letter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited, Scrip Code: 539561) has informed BSE that its Board of Directors will meet on April 24, 2025. The main item on the agenda is to approve the Letter of Offer for a proposed Rights Issue of 49,19,04,000 equity shares of Re. 1 each, aggregating to about ₹49.19 crore (₹4,919.04 lakhs). The rights issue will be offered to existing shareholders of the company. The company has also confirmed that the trading window for insiders is already closed from April 1, 2025 and will reopen only 48 hours after the audited financial results for FY25 are declared.
Existing shareholders should expect a potential dilutive rights issue worth about ₹49.19 crore; they may get the opportunity to subscribe to additional shares in proportion to their existing holdings, subject to board approval on April 24.